An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42.

Fiche publication

Date publication

janvier 2025

Journal

Breast (Edinburgh, Scotland)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry

Tous les auteurs :
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, Da Costa Vieira RA, Hoefnagels N, Huang CS, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala M, Shimomura A, Sturm-Inwald E, Getu MA, Bliem B, Astrup G, Morag O, Kikawa Y, Kuljanic K, Nevries N, Sprangers M, Aaronson N, Sinai P, Tomaszweski K, Galalae R, Conroy T, Duhoux F, Chie WC, Velikova G,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39947087

Résumé

The EORTC QLQ-BR23, published in 1996, was one of the first disease-specific questionnaires to assess health-related quality of life (HRQoL) in patients with breast cancer (BC). In the last decades, major changes in BC treatment have occurred, requiring an update of this module. The results of the Phase 1-3 of the study were published in 2019. The aim of study was to examine the psychometric properties of the provisional EORTC-QLQ-BR45.questionnaire.